CAS: 4707-32-8; 2,2-Dimethyl-3,4-Dihydro-2H-Benzo[h]Chromene-5,6-Dione

该化合物是源于拉帕乔树树树皮的自然形成的环烷酮,以其潜在的治疗特性而著称;它有C15H10O2分子分子配方,具有独特的双环结构,有助于其生物活动;该化合物具有一系列药理效应,包括抗癌,抗炎和抗微生物特性,使其成为医药化学的一个主题; -帕帕松作为红氧化活性剂,能够产生反应性氧物种,在癌症细胞中引起吸附性病;此外,还研究该化合物在提高某些乳胶制剂功效方面的作用,其典型特征是黄色晶状,在有机溶剂中可溶性;其稳定性和再活性可能受到环境因素的影响,如pH和温度.

结构式图片

上下游产品

α-lapachone Lapachol 2-hydroxy-3-(3-methyl-3-sulfooxy-butyl)-[1,4]naphthoquinone H-benzo[h]chromene5,6-diacetoxy-2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromeneH-benzo[h]chromene5,6-diacetoxy-2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene 7,8-dihydro-9,9-dimethyl-9H-pyrano[3',2':4]naphtha[1,2-b]quinoxaline 3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]-pyran α-lapachone

合成工艺路线路线简述

    去氧拉巴醌置于iron(Iii) Chloride,对甲苯磺酸体系中,用 水,甲苯 作为反应溶剂,化学反应 0.5H,以76%的收率获得产物3,4-二氢-2,2-二甲基-2H-萘并[1,2-B]吡喃-5,6-二酮
    参考文献:β-Lapachone 的合成,一种来自 Lapacho 树的潜在抗癌剂
    标题:β-Lapachone 的合成,一种来自 Lapacho 树的潜在抗癌剂
    摘要:一种药学上重要的天然产物 β-拉帕酮从市售的 1,4-萘醌开始,分四步有效合成,总产率为 70%.合成的关键步骤是通过有利的环化/水合/氧化级联过程将 2-异戊二烯-1,4-萘醌直接转化为 β-拉帕酮.
    DOI:10.1002/ejoc.201403064

    海关参考信息

    专利信息


    专利号:US-2017283878-A1
    优先权日:2015-12-11
    标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
    发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING
    权利人:ACADEMIA SINICA
    摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.

    专利号:US-5763625-A
    优先权日:1995-04-25
    标 题:Synthesis and use of β-lapachone analogs
    发明人:BOOTHMAN DAVID A; FRYDMAN BENJAMIN J; WITIAK DONALD T
    权利人:WISCONSIN ALUMNI RES FOUND
    摘要:3-Substituted-β-lapachone analogs and their use either alone or to augment chemotherapy or radiotherapy to induce programmed neoplastic cell death without exhibiting toxicity to surrounding normal cells are disclosed. In particular, 3-allyl-β-lapachones, 3-alkyl-β-lapachones and 3-halo-β-lapachones were found to be Topoisomerase (Topo I) inhibitors. When these analogs are used alone there is a reversible single-strand break in the DNA of neoplastic cells causing apoptosis and cell death in some cells. However, when these analogs are combined with chemotherapy or X-irradiation, an irreversible Topo I-mediated break is achieved. A new and more efficient chemical synthesis of the compounds is also disclosed.

    专利号:US-6458974-B1
    优先权日:2001-01-25
    标 题:Synthesis of β-lapachone and its intermediates
    发明人:JIANG ZHIWEI; HOGELAND JANE
    权利人:CYCLIS PHARMACEUTICALS INC
    摘要:A novel process for synthesizing beta-lapachone (beta-lapachone), an agent that has demonstrated significant antineoplastic activity against human cancer lines. The process comprises the conversion of starting material, 2-hydroxy-1,4-naphothoquinone into beta-lapachone intermediate, lapachol. The lapachol is then converted to beta-lapachone by treatment with sulfuric acid and purified by recrystallization from ethanol. This novel process is extremely simple and provides beta-lapachone in excellent quality and high yield.

    专利号:US-7790765-B2
    优先权日:2007-04-30
    标题:Hydroxy sulfonate of quinone compounds and their uses
    发明人:BARTIS JUDIT; VOLCKOVA ERIKA; TANDON MANISH; LOWE DEIRDRE; REDMON MARTIN P
    权利人:ARQULE INC
    摘要:The present invention provides sodium 6-hydroxy-2,2-dimethyl-5-oxo-3,4,5,6-tetrahydro-2H-benzo(h)chromene-6-sulfonate, and its synthesis and uses in the treatment of cancer.

    专利号:CA-2436125-C
    优先权日:2001-01-25
    标题 :Synthesis of beta-lapachone and its intermediates

    专利号:CA-2436125-A1
    优先权日:2001-01-25
    标题 :Synthesis of beta-lapachone and its intermediates
    南京沛微生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.peiwill.com/index.html
    电话: 025-57027729👤
    📞南京沛微生物科技有限公司 ⚠️参考联系方式

    销售电话:025-57027729
    邮箱:15850702895@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州市宣明医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://xuanmingchem.com
    电话:0519-85525329👤
    📞 常州市宣明医药科技有限公司⚠️参考联系方式

    电话: 0519-85525329
    邮件:sales@xuanmingchem.com
    网址: http://xuanmingchem.com
    地址:江苏省常州市新北区汉江路120号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    江苏省常州市新北区汉江路120号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Kim JH, Lee SM, Myung CH, Lee KR, Hyun SM, Lee JE, Park YS, Jeon SR, Park JI, Chang SE, Hwang JS. Melanogenesis inhibition of β-lapachone, a natural product from Tabebuia avellanedae, with effective in vivo lightening potency. Arch Dermatol Res. 2015 Feb 8. [Epub ahead of print] doi: 10.1038/cddis.2014.564.
    3: Menacho-Márquez M, Rodríguez-Hernández CJ, Villaronga MÃ

    合成参考文献


    参考文献:10.1007/978-1-61779-182-6_7
    摘要:Iwamatsu T. Chromosome formation during fertilization in eggs of the teleost Oryzias latipes. Methods Mol Biol. 2011;761():97–124. doi: 10.1007/978-1-61779-182-6_7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知